178 related articles for article (PubMed ID: 13066148)
1. [A new assymetrical vitamin K antagonist: 3-(alpha-naphthyl)-4-hydroxycoumarin].
MORAUX J; MEUNIER P; MENTZER C
Arch Int Pharmacodyn Ther; 1953 May; 94(1):47-64. PubMed ID: 13066148
[No Abstract] [Full Text] [Related]
2. [Antivitamins K and blood coagulation: a new synthetic anticoagulant, alpha-naphthyl-3-hydroxy-4-coumarin].
MORAUX J
Therapie; 1956; 11(1):104-16. PubMed ID: 13337764
[No Abstract] [Full Text] [Related]
3. Clinical experiences with 4-hydroxycoumarin anticoagulant No. 63 and the antagonistic effect of menadione and vitamin K.
HANSON HH; BARKER NW; MANN FD
Circulation; 1951 Dec; 4(6):844-63. PubMed ID: 14879492
[No Abstract] [Full Text] [Related]
4. [Derivative of 4-hydroxycoumarin as a new anticoagulant].
KLOSA J
Pharmazie; 1954 Aug; 9(8):622. PubMed ID: 13224346
[No Abstract] [Full Text] [Related]
5. [Anticoagulant properties and therapeutic use of a new coumarin derivative: 3-[2-acetyl-1-(p-nitrophenol)-ethyl]-4-hydroxycoumarin or coumarin G 23350].
LEROUX M; JAMAIN B
Therapie; 1956; 11(1):85-101. PubMed ID: 13337762
[No Abstract] [Full Text] [Related]
6. [Ambulatory anticoagulant therapy with 3-(l-phenylpropyl)-4-hydroxycoumarin].
KNOBEL P
Praxis; 1956 Jan; 45(4):65-72. PubMed ID: 13310434
[No Abstract] [Full Text] [Related]
7. [A new anticoagulant: 3-(1-phenylpropyl)4-hydroxycoumarin; early clinical results].
VAN WIEN A; VEROFT R
Acta Clin Belg; 1953; 8(6):618-28. PubMed ID: 13137838
[No Abstract] [Full Text] [Related]
8. Marcumar [3-(1'-phenylpropyl)-4-hydroxycoumarin]; a new anticoagulant.
BOURGAIN R; TODD M; HERZIG L; WRIGHT IS
Circulation; 1954 Nov; 10(5):680-4. PubMed ID: 13209748
[No Abstract] [Full Text] [Related]
9. [Clinical data on anticoagulant treatment with 3-(1-phenylpropy1)-4-hydroxycoumarin].
VERGANI G
Gazz Med Ital; 1955 Dec; 114(12):269-73. PubMed ID: 13305779
[No Abstract] [Full Text] [Related]
10. Clinical evaluation of acenocoumarin, a new 4-hydroxycoumarin anticoagulant.
SCHILLING FJ; KRUESI OR
Am J Med Sci; 1956 May; 231(5):558-63. PubMed ID: 13313541
[No Abstract] [Full Text] [Related]
11. Synthesis and biological evaluation of C-3 aliphatic coumarins as vitamin K antagonists.
Montagut-Romans A; Boulven M; Jacolot M; Moebs-Sanchez S; Hascoët C; Hammed A; Besse S; Lemaire M; Benoit E; Lattard V; Popowycz F
Bioorg Med Chem Lett; 2017 Apr; 27(7):1598-1601. PubMed ID: 28254487
[TBL] [Abstract][Full Text] [Related]
12. [Independent hypoprothrombinemic action of anticoagulants derived from 4-hydroxycoumarin].
DERECHIN M
Prensa Med Argent; 1956 May; 43(20):1644. PubMed ID: 13370465
[No Abstract] [Full Text] [Related]
13. Bishydroxycoumarin, ethyl biscoumacetate, and 4-hydroxycoumarin anticoagulant No. 63; comparative effects.
BARKER NW; HANSON HH; MANN FD
J Am Med Assoc; 1952 Jan; 148(4):274-7. PubMed ID: 14888460
[No Abstract] [Full Text] [Related]
14. Comparison of the anticoagulant action of 3-(alpha-p-chlorphenyl-beta-acetylethyl)-4-hydroxycoumarin (coumachlor) and dicoumarol in chicks and rats.
DAM H; SØNDERGAARD E
Acta Pharmacol Toxicol (Copenh); 1953; 9(2):137-47. PubMed ID: 13079850
[No Abstract] [Full Text] [Related]
15. [Anticoagulant 3-(1-phenyl-propyl)-4-hydroxycoumarin in the treatment of phlebothrombosis and thrombophlebitis].
PERCESEPE E
Rass Int Clin Ter; 1956 Jul; 36(14):419-24. PubMed ID: 13379678
[No Abstract] [Full Text] [Related]
16. New anticoagulant for oral use-3-(1'-phenylpropyl)-4 hydroxycoumarin (liquamar); its evaluation for short-term therapy.
GOLD H; LILLEY GW
J Am Med Assoc; 1959 Jul; 170(11):1303-6. PubMed ID: 13664522
[No Abstract] [Full Text] [Related]
17. [Antibacterial activity of compounds possessing a tricarbonylmethane group. X. Observations on the acetylation of 4-hydroxycoumarin and synthesis of 3-(alpha-aminophenylacetyl)-4-hydroxycoumarins].
ARAKAWA K
Pharm Bull; 1953 Dec; 1(4):331-4. PubMed ID: 13166555
[No Abstract] [Full Text] [Related]
18. [Phenylpropyl hydroxycoumarin as anticoagulant in obstetric and gynecological thrombophlebitis and its antidote, vitamin K1].
DE DOMINICIS E; ROLANDI L
Riv Ostet Ginecol Prat; 1955 Nov; 37(11):658-65. PubMed ID: 13281402
[No Abstract] [Full Text] [Related]
19. [The possible tautomeric forms of 4-hydroxycoumarin].
KLOSA J
Arch Pharm Ber Dtsch Pharm Ges; 1953; 23(1):37-43. PubMed ID: 13066059
[No Abstract] [Full Text] [Related]
20. The secretion of 3,3'-ethylidene bis (4-hydroxycoumarin) in milk.
FANTL P; NELSON JF
Med J Aust; 1952 Mar; 1(12):404-5. PubMed ID: 14918772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
